Post-mRNA COVID-19 Vaccination Myocarditis
A new trend of myocarditis among young adults who received mRNA vaccines for COVID-19 is emerging. We present the case of a young adult who presented with chest pain 3 days after the second dose of Pfizer-BioNTech COVID-19 vaccine. He had elevated troponin I and C-reactive protein levels at the time...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2021-08-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/2769 |
id |
doaj-afc82499cb9c49ac9fe954b8525b0979 |
---|---|
record_format |
Article |
spelling |
doaj-afc82499cb9c49ac9fe954b8525b09792021-09-03T07:43:48ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942021-08-0110.12890/2021_0027692385Post-mRNA COVID-19 Vaccination MyocarditisAbhishek Matta0Rekha Kallamadi1Danielle Matta2Dinesh Banda3 University of North Dakota School of Medicine and Health Sciences, Grand Forks, USUniversity of North Dakota School of Medicine and Health Sciences, Grand Forks, USA; Sanford Health, Fargo, USASanford Health, Fargo, USAUniversity of North Dakota School of Medicine and Health Sciences, Grand Forks, USA; Sanford Health, Fargo, USAA new trend of myocarditis among young adults who received mRNA vaccines for COVID-19 is emerging. We present the case of a young adult who presented with chest pain 3 days after the second dose of Pfizer-BioNTech COVID-19 vaccine. He had elevated troponin I and C-reactive protein levels at the time of admission. Electrocardiogram (ECG) and echocardiogram findings were unremarkable. The patient improved with conservative management and was discharged home the next day.https://www.ejcrim.com/index.php/EJCRIM/article/view/2769covid-19myocarditiscovid-19 vaccine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Abhishek Matta Rekha Kallamadi Danielle Matta Dinesh Banda |
spellingShingle |
Abhishek Matta Rekha Kallamadi Danielle Matta Dinesh Banda Post-mRNA COVID-19 Vaccination Myocarditis European Journal of Case Reports in Internal Medicine covid-19 myocarditis covid-19 vaccine |
author_facet |
Abhishek Matta Rekha Kallamadi Danielle Matta Dinesh Banda |
author_sort |
Abhishek Matta |
title |
Post-mRNA COVID-19 Vaccination Myocarditis |
title_short |
Post-mRNA COVID-19 Vaccination Myocarditis |
title_full |
Post-mRNA COVID-19 Vaccination Myocarditis |
title_fullStr |
Post-mRNA COVID-19 Vaccination Myocarditis |
title_full_unstemmed |
Post-mRNA COVID-19 Vaccination Myocarditis |
title_sort |
post-mrna covid-19 vaccination myocarditis |
publisher |
SMC MEDIA SRL |
series |
European Journal of Case Reports in Internal Medicine |
issn |
2284-2594 |
publishDate |
2021-08-01 |
description |
A new trend of myocarditis among young adults who received mRNA vaccines for COVID-19 is emerging. We present the case of a young adult who presented with chest pain 3 days after the second dose of Pfizer-BioNTech COVID-19 vaccine. He had elevated troponin I and C-reactive protein levels at the time of admission. Electrocardiogram (ECG) and echocardiogram findings were unremarkable. The patient improved with conservative management and was discharged home the next day. |
topic |
covid-19 myocarditis covid-19 vaccine |
url |
https://www.ejcrim.com/index.php/EJCRIM/article/view/2769 |
work_keys_str_mv |
AT abhishekmatta postmrnacovid19vaccinationmyocarditis AT rekhakallamadi postmrnacovid19vaccinationmyocarditis AT daniellematta postmrnacovid19vaccinationmyocarditis AT dineshbanda postmrnacovid19vaccinationmyocarditis |
_version_ |
1717817618284412928 |